Divis Laboratories Q1 net spurts 45% to Rs 243 crore
Drug firm Divis Laboratories today reported a 45 per cent rise in its net profit at Rs 243.18 crore for the June quarter.
By PTI | Updated:
NEW DELHI: Drug firm Divis Laboratories today reported a 45 per cent rise in its net profit at Rs 243.18 crore for the June quarter, from Rs 167.93 crore a year ago.
Net sales of the company rose to Rs 806.91 crore for the first quarter as against Rs 639.76 crore in the year-ago quarter, Divis Laboratories said in a filing to BSE.
"Forex translation gain for the current quarter amounted to Rs 21 crore as against a gain of Rs 1 crore during the corresponding quarter of the last year," it added.
The company's board, which met today, has recommended bonus shares in the ratio of 1:1.
Net sales of the company rose to Rs 806.91 crore for the first quarter as against Rs 639.76 crore in the year-ago quarter, Divis Laboratories said in a filing to BSE.
"Forex translation gain for the current quarter amounted to Rs 21 crore as against a gain of Rs 1 crore during the corresponding quarter of the last year," it added.
The company's board, which met today, has recommended bonus shares in the ratio of 1:1.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Divi's Laboratories Q4 Results: Cons PAT grows 13% YoY to Rs 751 crore, revenue up 10%; Rs 30 per share dividend announced2026-05-23T08:21:07Z- Jefferies' pharma bets are Divi's Laboratories and 3 smallcaps, with up to 30% upside. Here's why2025-09-12T12:13:16Z
- Sell Divi's Laboratories, target price Rs 4,500: ICICI Securities2025-02-05T04:21:00Z
ADVERTISEMENT
